Quince Therapeutics的动态

Coeptis Therapeutics Holdings Inc is a biotechnology company specializing in the development of innovative therapeutics within the healthcare sector. Today, the ticker COEP has moved 11.29%. This significant movement indicates that Coeptis Therapeutics Holdings Inc should be monitored as a potential trade based on today's performance.

Key stakeholders representing drugmakers, generics manufacturers, and biotechnology companies have asked FDA to harmonize recent guidances related to developing oligonucleotide-based therapeutics. Ferdous Al-Faruque reports in Regulatory Focus: https://hubs.la/Q034tBY30

Global Biopharmaceuticals and Biotechnology Equity Research Analyst Vamil Divan, MD, MBA joins CNBC to discuss the initial 2025 guidance presented by a leading global biopharmaceutical company and why he's optimistic about the various therapeutics in the company's product pipeline. Watch his segment: https://lnkd.in/ev9CwYWc Learn more about Guggenheim Securities Healthcare Research: https://lnkd.in/eSgTkerH

Thoughts on this? >> Private Danish iron deficiency biotech to buy G1 Therapeutics for $405M >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #productmarketing

SFBN Feed: Cellipont Bioservices and Xiogenix Announce Strategic Partnership to Enhance Client Access to Advanced Filling Systems https://lnkd.in/gmMpn54d THE WOODLANDS, Texas and MUSKEGO, Wis., Dec. 10, 2024 /PRNewswire/ — Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Xiogenix, an innovator in biopharmaceutical technology, are pleased to announce a [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

In this webinar ICON experts discuss considerations for Oligonucleotide therapeutics in CMC, including the critical quality attributes (CQAs) and critical process parameters (CPPs) in oligonucleotide drug product development, key aspects of manufacturing, stability, and scalability, and guidance on setting and meeting specifications to ensure quality and compliance when progressing into early phase studies. Register here: https://ow.ly/YeAg50SMUv7

There are more than 300 GLP-1RAs in an active stage of development, from industry giants and potential market disrupters. While mega-cap companies dominate the GLP-1RA market and are expected to maintain their stronghold in 2030, three smaller biotechs – Viking Therapeutics, Inc., Altimmune, Inc., and Structure Therapeutics – are emerging as potential disrupters in this drug category, giving hope to innovative newcomers. Click here for the full article - https://lnkd.in/d8QNQ6z7 #pharma #GLP1 #biotech #biopharma

I like this configuration.

?? Cell line development (CLD) is crucial for producing high-quality protein therapeutics, and ensuring stability early is key. In a new article from BioPharm International, Roxana McCloskey and Zo? Yuzhuo Zhang highlight how integrated CE–MS technologies, including ours, are transforming CLD by providing precise data on product quality and stability. Discover how these innovations are driving the development of stable cell lines for bioproduction in BioPharm International's new 'Emerging Therapies' ebook. ?? Read the full article here: https://bit.ly/3BvmioM ?? Stay up to date on the latest in biopharmaceutical and pharmaceutical solutions from SCIEX by following SCIEX Biopharma & Pharma Solutions #DanaherNews #ProteinTherapeutics #CellLineDevelopment #Biotherapeutics #MassSpectrometry #WhenItCounts #SCIEXforScience #BioPharmInternational #EmergingTherapies #InTheNews #DanaherNews

Upcoming FDA/PDUFA Catalysts Calendar for the June 2024 Please stay tuned for the latest biotech catalysts to shape the industry in the coming months. Full free access here: https://lnkd.in/ek7dAfUx Here are some of the key companies with significant upcoming milestones: ?? $AVTE - Aerovate Therapeutics, Inc. ?? $IRWD - Ironwood Pharmaceuticals ?? $PLRX - Pliant Therapeutics ?? $INSM - Insmed Incorporated ?? $BMY - Bristol Myers Squibb ?? $ABEO - Abeona Therapeutics ?? $BHVN - Biohaven ?? $MGNX - MacroGenics, Inc. ?? $SWTX - SpringWorks Therapeutics (also mentioned twice) ?? $IOVA - Iovance Biotherapeutics, Inc. ?? $MOR - MorphoSys ?? $NXTC - NextCure, Inc. ?? $CYCC - Cyclacel Limited?? $MURA - Mereo BioPharma ?? $RCUS - Arcus Biosciences ?? $BGNE - BeiGene (also mentioned twice) ?? $KRON - Kronos Bio ?? $ERAS - Erasca, Inc. ?? $SNSE - Sensei Biotherapeutics ?? $CRBP - Corbus Pharmaceuticals...many more Monitor these companies as their innovative treatments progress through critical regulatory reviews. Join the conversation and stay updated on the latest industry developments! #Biotech #Pharma #Investing #FDA #PDUFA #ClinicalTrials #DrugDevelopment #Biopharma